Average Co-Inventor Count = 7.62
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (16 from 2,405 patents)
2. Merck + Co., Inc. (2 from 4,770 patents)
3. Columbia University (1 from 2,489 patents)
4. Msd R&d (china) Co., Ltd. (1 from 10 patents)
5. Msd R&d Co., Ltd. (0 patent)
19 patents:
1. 11066396 - 3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors
2. 10647727 - Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors
3. 10351558 - Factor IXa inhibitors
4. 10174037 - Dihydropyrazolopyrimidinone compounds as PDE2 inhibitors
5. 10160762 - 6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors
6. 10065945 - Isoquinoline derivatives as MGAT2 inhibitors
7. 9815796 - Pyrimidone carboxamide compounds as PDE2 inhibitors
8. 8748433 - β3 adrenergic receptor agonists
9. 8653260 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10. 8642798 - Silacycle compounds and methods of use thereof
11. 8501786 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
12. 8399480 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
13. 8354403 - Pyrrolidine derived beta 3 adrenergic receptor agonists
14. 8247415 - Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists
15. 7977339 - Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators